Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr 2;28(7):3160.
doi: 10.3390/molecules28073160.

Endoplasmic Reticulum Stress and Mitochondrial Stress in Drug-Induced Liver Injury

Affiliations
Review

Endoplasmic Reticulum Stress and Mitochondrial Stress in Drug-Induced Liver Injury

Sisi Pu et al. Molecules. .

Abstract

Drug-induced liver injury (DILI) is a widespread and harmful disease closely linked to mitochondrial and endoplasmic reticulum stress (ERS). Globally, severe drug-induced hepatitis, cirrhosis, and liver cancer are the primary causes of liver-related morbidity and mortality. A hallmark of DILI is ERS and changes in mitochondrial morphology and function, which increase the production of reactive oxygen species (ROS) in a vicious cycle of mutually reinforcing stress responses. Several pathways are maladapted to maintain homeostasis during DILI. Here, we discuss the processes of liver injury caused by several types of drugs that induce hepatocyte stress, focusing primarily on DILI by ERS and mitochondrial stress. Importantly, both ERS and mitochondrial stress are mediated by the overproduction of ROS, destruction of Ca2+ homeostasis, and unfolded protein response (UPR). Additionally, we review new pathways and potential pharmacological targets for DILI to highlight new possibilities for DILI treatment and mitigation.

Keywords: ERS; drug-induced liver injury; mitochondrial stress.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Mitochondrial stress and ERS in APAP and INH-induced liver injury. (APAP: Acetaminophen; NAPQI: N-acetyl-p-benzoquinone imine; ROS: Radical Oxygen Species; JNK: c-jun N-terminal kinase; MPT: Mitochondrial phosphate transporter; Bax: BCL2-Associated X; INH: Isoniazid; mit stress: Mitochondrial stress; mt DNA: Mitochondrial Deoxyribonucleic acid; GSH: Glutathione; ERS: Endoplasmic reticulum stress; TCA: Tricarboxylic acid).
Figure 2
Figure 2
SPHK1 pathway in liver injury. (SPHK1: sphingosine kinase-1; S1P: Sphingosine-1-phosphate; PERK: PKR-like ER kinase; IRE1α; Inositol-requiring enzyme-1α; CHOP: C/EBP-homologous Protein; ATF4: Activating Transcription Factor 4; ATF6: Activating Transcription Factor 6; ASK1: Apoptosis signal-regulating kinase 1; GSK3β: Glycogen Synthetase Kinase 3β; TRAF2: TNF receptor-associated factor 2; NF-κB: Nuclear Factor Kappa B).
Figure 3
Figure 3
ATF6 pathway. (S2P: Sphingosine-1-phosphate; ERSE: ERS-response element; BIP: binding protein; XBP1: X-box binding protein 1).
Figure 4
Figure 4
IRE1 pathway. (S2P: Sphingosine-1-phosphate; ERSE: ERS-response element; BIP: binding protein; XBP1: X-box binding protein 1).
Figure 5
Figure 5
PERK pathway.
Figure 6
Figure 6
Caspase-12 pathway.
Figure 7
Figure 7
Mitochondrial stress pathways.
Figure 8
Figure 8
Communication between the ERS and mitochondria stress (LONP1: Lon peptidase1; VDAC1: Voltage dependent anion channel protein 1; IP3R: Inositol 1,4,5 triphosphate receptor; MFN1: Mitofusin 1; MFN2: Mitofusin 2; Sig-1R: Sigma 1 receptor; DELE1: DAP3 binding cell death enhancer 1).

References

    1. Björnsson H., Björnsson E. Drug-induced liver injury: Pathogenesis, epidemiology, clinical features, and practical management. Eur. J. Intern. Med. 2022;97:26–31. doi: 10.1016/j.ejim.2021.10.035. - DOI - PubMed
    1. Reuben A., Koch D.G., Lee W.M. Drug-induced acute liver failure: Results of a U.S. multicenter, prospective study. Hepatology. 2010;52:2065–2076. doi: 10.1002/hep.23937. - DOI - PMC - PubMed
    1. Ou P., Liu X., Tang Z., Hou Z., Liu L., Liu J., Zhou S., Fang Z., Sun K., Chen Y., et al. Gynura Segetum Related Hepatic Sinusoidal Obstruction Syndrome: A Liver Disease with High Mortality and Misdiagnosis Rate. Curr. Pharm. Des. 2019;25:3762–3768. doi: 10.2174/1381612825666191007162024. - DOI - PubMed
    1. Iorga A., Dara L. Cell death in drug-induced liver injury. Adv. Pharmacol. 2019;85:31–74. doi: 10.1016/bs.apha.2019.01.006. - DOI - PubMed
    1. Chang L., Xu D., Zhu J., Ge G., Kong X., Zhou Y. Herbal Therapy for the Treatment of Acetaminophen-Associated Liver Injury: Recent Advances and Future Perspectives. Front. Pharmacol. 2020;11:313. doi: 10.3389/fphar.2020.00313. - DOI - PMC - PubMed

MeSH terms

Substances